Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             42 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A new era for respiratory syncytial virus infection control The Lancet Infectious Diseases,

25 6 p. 595
artikel
2 Anna Banerji—champion for Canada’s Indigenous peoples Kirby, Tony

25 6 p. 612
artikel
3 Another antimalarial mass drug administration? von Seidlein, Lorenz

25 6 p. 602-604
artikel
4 Arboviral infections in southeast Europe: ongoing challenges for diagnosis, outbreak investigation, and preparedness Burt, Felicity Jane

25 6 p. 605-607
artikel
5 Correction to Lancet Infect Dis 2025; 25: 690–700
25 6 p. e320
artikel
6 Correction to Lancet Infect Dis 2025; 25: e345–52
25 6 p. e320
artikel
7 Correction to Lancet Infection 2025; published online March 24. https://doi.org/10.1016/S1473-3099(25)00181-1
25 6 p. e320
artikel
8 Countries reach consensus on pandemic agreement Burki, Talha

25 6 p. e327-e328
artikel
9 COVID-19 versus influenza: the need to align policies with COVID-19 realities Xie, Yan

25 6 p. 596-597
artikel
10 Development of the Mycetoma Activity and Severity clinical Scale (MASS): an international Delphi study Chandler, David J

25 6 p. e345-e352
artikel
11 Doxy-PEP could select for ceftriaxone resistance in Neisseria gonorrhoeae Vanbaelen, Thibaut

25 6 p. e316
artikel
12 Doxy-PEP could select for ceftriaxone resistance in Neisseria gonorrhoeae – Authors' reply Luetkemeyer, Anne F

25 6 p. e317
artikel
13 Effect of mass campaigns with full and fractional doses of pneumococcal conjugate vaccine (Pneumosil) on the reduction of nasopharyngeal pneumococcal carriage in Niger: a three-arm, open-label, cluster-randomised trial Coldiron, Matthew E

25 6 p. 634-642
artikel
14 Effect of mass drug administration on malaria incidence in southeast Senegal during 2020–22: a two-arm, open-label, cluster-randomised controlled trial Ba, El-hadji Konko Ciré

25 6 p. 656-667
artikel
15 Efficacy of 8-aminoquinolines for Plasmodium vivax malaria radical cure: only one part of the problem Lacerda, Marcus

25 6 p. 604-605
artikel
16 Exploring parvovirus B19 pathogenesis and therapy among kidney transplant recipients: case report and review of literature Berti, Gian Marco

25 6 p. e360-e368
artikel
17 Future immunisation strategies to prevent Streptococcus pneumoniae infections in children and adults Ramos, Bernice

25 6 p. e330-e344
artikel
18 Highlights of ESCMID Global 2025 Hassan, Syeda Saleha

25 6 p. e321
artikel
19 Impact of the Global Fund Regional Artemisinin-resistance Initiative on malaria control and elimination in the Greater Mekong subregion of southeast Asia Pley, Caitlin

25 6 p. e353-e359
artikel
20 Infectious disease surveillance update McQuillan, Cahal

25 6 p. e328
artikel
21 Malaria prophylaxis in sickle cell anaemia: some answers, more questions Williams, Thomas N

25 6 p. 601-602
artikel
22 Martin Danis Bagcchi, Sanjeet

25 6 p. 611
artikel
23 Mass doses of fractional pneumococcal vaccine in humanitarian settings Russell, Fiona M

25 6 p. 599-601
artikel
24 Multi-antigen serology and a diagnostic algorithm for the detection of arbovirus infections as novel tools for arbovirus preparedness in southeast Europe (MERMAIDS-ARBO): a prospective observational study Kasbergen, Louella M R

25 6 p. 678-689
artikel
25 New flavours of tuberculosis treatment for children Holt, Ed

25 6 p. e322
artikel
26 Prevalence, clinical management, and outcomes of adults hospitalised with endemic arbovirus illness in southeast Europe (MERMAIDS-ARBO): a prospective observational study Sigfrid, Louise

25 6 p. 690-700
artikel
27 Progressive centrofacial destruction due to Acanthamoeba infection from nasal rinsing Sreekantaswamy, Shreya A

25 6 p. e369
artikel
28 Quantifying Plasmodium vivax radical cure efficacy: a modelling study integrating clinical trial data and transmission dynamics Ciavarella, Constanze

25 6 p. 668-677
artikel
29 Research in brief Venkatesan, Priya

25 6 p. e329
artikel
30 Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation study Bajema, Kristina L

25 6 p. 625-633
artikel
31 Respiratory syncytial virus vaccine in older adults did not reduce invasive pneumococcal disease incidence in England Rooney, Graeme

25 6 p. 609-610
artikel
32 RSV vaccines: an elixir for healthy ageing? Nair, Harish

25 6 p. 597-599
artikel
33 Social workers and neglected tropical diseases Bagcchi, Sanjeet

25 6 p. 614
artikel
34 Strengthening health systems Ranscombe, Peter

25 6 p. 613
artikel
35 The fallout of US HHS layoffs on infectious disease control Balakrishnan, Vijay Shankar

25 6 p. e325-e326
artikel
36 The history of phage therapy Burki, Talha

25 6 p. 615
artikel
37 The hospital and mortality burden of COVID-19 compared with influenza in Denmark: a national observational cohort study, 2022–24 Bager, Peter

25 6 p. 616-624
artikel
38 Underimmunisation during the 2025 Texas measles outbreak Hulland, Erin N

25 6 p. 607-609
artikel
39 Vaccines and long COVID Bagcchi, Sanjeet

25 6 p. e323
artikel
40 Weekly dihydroartemisinin–piperaquine versus monthly sulfadoxine–pyrimethamine for malaria chemoprevention in children with sickle cell anaemia in Uganda and Malawi (CHEMCHA): a randomised, double-blind, placebo-controlled trial Idro, Richard

25 6 p. 643-655
artikel
41 WHO prequalifies maternal RSV vaccine to protect infants Jesudason, Timothy

25 6 p. e324
artikel
42 Why now? The measles controversy Branda, Francesco

25 6 p. e318-e319
artikel
                             42 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland